Boston Scientific Brings Heart Puncture Patent Suit
Boston Scientific has sued Johnson & Johnson-owned medical device company Atraverse Medical Inc., claiming it infringed a patent covering a method of puncturing heart tissue.
Search fresh public links, source activity, and ready-to-use post angles for Boston Scientific.
Fresh curated links around Boston Scientific are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Boston Scientific has sued Johnson & Johnson-owned medical device company Atraverse Medical Inc., claiming it infringed a patent covering a method of puncturing heart tissue.
Top News Boston Scientific reports that a cyberattack is disrupting ...
Boston Scientific said on Wednesday that a cybersecurity incident had disrupted global operations, including some information systems used to process and ship customer orders. The...
Boston Scientific went from $105.65 in November to about $43.55 this month. That is roughly a 59% collapse. Then the CEO stepped in and bought $9 million of his own company’s stock...
Boston Scientific is working to restore its manufacturing, order processing, and distribution capabilities following a cybersecurity incident that caused a network outage across ce...
On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment del...
Boston Scientific is investigating a cybersecurity incident that disrupted parts of its global operations, affecting manufacturing, order processing, and product shipments. The com...
Boston Scientific disclosed a cyberattack disrupting its global IT systems and order shipping capabilities, with the company unable to provide a timeline for when normal operations...
MedTech giant Boston Scientific has revealed IT outages following a cyber incident
SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis The US Food and Drug Administration has approved the SELUTION SLR™ (Sustained Limus Release) Drug-Eluting Bal...
Boston Scientific said on Tuesday it no longer expects to meet its previously issued third-quarter and full-year 2026 sales and adjusted profit forecasts, after a cybersecurity inc...
The attack affected global operations, and its full scope is still being determined, the medical device maker said in a securities filing.
The $69bn company expects further disruption while it works to restore affected systems. Read more: Boston Scientific cyberattack: Cork staff asked to work remotely
Of the 10 companies earning top honors from Fast Company judges in the biotech, healthcare, and life sciences fields category of Best Workplaces for Innovators 2026, half are in th...
Medical device giant warns August intrusion will hit Q3 and full-year sales and earnings as recovery drags on
Brokers face growing questions over operational resilience and BI coverage
The medical device specialist was the victim of a cyberattack.
The company won't say if medical devices are affected or if any customer data was exfiltrated.
KEELE, United Kingdom, Sept. 09, 2026 (GLOBE NEWSWIRE) — Biocomposites, an international medical devices company that engineers, manufactures…
The Federal Circuit on Wednesday denied a bid from the University of Texas to get a panel to rehear its patent infringement case where a $49.4 million jury verdict against Boston S...
The €62bn medical device maker confirmed this week that it had suffered an attack which has disrupted its global operations
September 8, 2026 – Bioretec Ltd (“Bioretec” or the “Company”), a pioneer in bioabsorbable orthopedic implants, has received…
Acquisition adds proven PzFâ„¢ thin-film surface modification technology, specialized blood- and tissue-contacting device expertise and a West Coast testing facility
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.